NCT04652882Phase 3Active not recruiting

Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)

Study sponsor: Vanda Pharmaceuticals

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2026-09Estimated
Enrollment · participants70Estimated
Source updated2026-07-27Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 2 fields changed

Primary completion date

Recorded edit
− Previous value

2026-06

+ Updated value

2026-09

Recruitment status

Recorded edit
− Previous value

Recruiting

+ Updated value

Active not recruiting

Check registry source

· 1 field changed

Primary completion date

Recorded edit
− Previous value

2025-12

+ Updated value

2026-06

Check registry source